Download Global EHR and Health IT Growth Markets 2026–2030: 13 Next-Wave Countries

Black Book Research has published a 117-page independent market-opportunity and vendor-benchmark study to help health ministries, hospital and health-system executives, EHR and hospital information system suppliers, interoperability platform providers, global growth officers, international sales and product leaders, implementation partners, cloud and cybersecurity providers, consultants, investors, and procurement teams identify where the strongest next-stage healthcare technology opportunities are developing through 2030.

Built as an executive-ready country portfolio and market-entry analysis, the report evaluates international EHR and health IT expansion as a series of distinct national transformation environments rather than as a single worldwide market-growth rate or population ranking. It examines government mandates and procurement triggers, remaining digitisation runway, purchasing capacity and health-system scale, interoperability and national-platform momentum, commercial accessibility, local ecosystem strength, implementation complexity, and the visibility of near-term purchasing activity.

The study compares 13 markets across Europe, the Middle East, Asia-Pacific, Africa, and Latin America. Collectively, these countries represent 2.62 billion people, or 31.8% of the world population measured in the report. The analysis is supported by government, statutory, procurement, national-program, and multilateral evidence verified through 21 July 2026, together with Black Book’s proprietary six-dimension, 100-point Opportunity Index and country-level evidence-confidence assessments.

Saudi Arabia ranks first with an Opportunity Index of 92, followed by Ireland at 89, Malaysia at 86, Indonesia at 84, India at 83, Brazil at 80, Vietnam at 78, the Philippines at 75, South Africa at 73, Mexico at 70, the United Arab Emirates at 68, Poland at 65, and Egypt at 62. Black Book assigns 0.90 confidence to the selection of the 13-country portfolio, a weighted mean evidence-confidence rating of 0.87, and 0.78 confidence to the exact ordinal ranking.

The report organises the markets into four practical market-entry archetypes:

  • Centrally driven transformation: Saudi Arabia, Ireland, and Malaysia

  • National-platform and interoperability expansion: Indonesia, India, and Brazil

  • Implementation-scale and provincial digitisation: Vietnam, the Philippines, South Africa, and Mexico

  • Advanced optimisation and developing watchlist markets: United Arab Emirates, Poland, and Egypt

Each country chapter includes verified market signals, health-system and buyer structures, priority technology segments, procurement and policy drivers, technical and localisation requirements, commercial risks, implementation watchpoints, a first 12-month vendor action plan, and a 2026–2030 outlook. The analysis covers core EHR and HIS platforms, interoperability and health information exchange, patient identity, claims and revenue cycle, implementation services, cloud and cybersecurity, analytics and AI, and patient-access technologies.

To keep market opportunity separate from vendor performance, the report also presents two clearly dated Black Book evidence layers: the latest available 2025 client-evaluation order and the most recent publicly retrievable 2024 detailed 18-KPI client-score baseline. Country-specific, regional, proxy, and unreported evidence is explicitly identified. Benchmark leaders represented across the chapters include Oracle Health, MEDITECH Expanse, Medica CloudXCare by HealthInsights Asia, Kranium, MV Sistemas, FPT Information Systems, MEDITECH, CompuGroup Medical, and other regional and global suppliers.

Global EHR And Health IT Growth Markets 2026 2030 13 Next Wave Countries

What the Report Helps You Do

  • Prioritise which countries warrant immediate market investment, national-platform positioning, implementation-scale expansion, selective advanced-market pursuit, or continued opportunity validation.

  • Separate demand for core EHR and HIS platforms, interoperability and HIE, claims and revenue-cycle technology, implementation and consulting services, cloud and cybersecurity, analytics and AI, and patient-access solutions before committing international business-development resources.

  • Evaluate each market through 18 country-adapted performance areas covering national-policy alignment, localisation and clinical workflow, interoperability, patient identity, usability, data migration, implementation governance, workforce training, infrastructure resilience, cloud and data sovereignty, cybersecurity, payer connectivity, analytics, AI governance, local support, contract integrity, multisite scalability, and benefits realisation.

  • Build country-specific market-entry plans around procurement status, language and workflow localisation, data residency, implementation capacity, migration, training, field support, partner selection, commercial terms, and measurable post-live outcomes.

  • Distinguish national strategy announcements, account totals, connected-facility counts, procurements, implementations, active production use, and realised clinical value rather than treating every digital-health statistic as equivalent commercial demand.

  • Use the report’s market qualification gates, evidence-confidence ratings, vendor baselines, and cross-country comparisons to support portfolio planning, partnership decisions, account targeting, product localisation, bid qualification, and international investment decisions.